FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Claudia Abramjuk

Research Profile

Chemicals & Drugs

Disorders

Living Beings

Concepts & Ideas

Drug Dose Response Relationship

Procedures

Devices

Stents

Anatomy

Physiology

Cell Proliferation

Co-author Network

Publications

TOP 3
Juan R Rodrigues; Arthur Barazarte; José Camacho; Jaime Charris; Neira Gamboa; Michael Höpfner; Klaus Jung; Michael Lein; Bianca Nitzsche; Claudia Abramjuk
N'-Formyl-2-(5-nitrothiophen-2-yl)benzothiazole-6-carbohydrazide as a potential anti-tumour agent for prostate cancer in experimental studies.
Juan R Rodrigues; Jorge Angel; Jaime Charris; Rosa Ferrer; Neira Gamboa; Michael Hoepfner; Klaus Jung; Michael Lein; Bianca Nitzsche; Claudia Abramjuk
Effect of quinolinyl acrylate derivatives on prostate cancer in vitro and in vivo.
Tobias Lange; Imke Müller; Michael F Nentwich; Guido Sauter; Thorsten Schlomm; Jennifer Schröder-Schwarz; Claudia Abramjuk; Mario Anders; Susanne Feldhaus; Olaf J C Hellwinkel; Hartwig Huland; Christine Knies; Katrin Stübke; Sebastian Ullrich; Robert L Vessella; Udo Schumacher
Human prostate cancer in a clinically relevant xenograft mouse model: identification of β(1,6)-branched oligosaccharides as a marker of tumor progression.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Claudia Abramjuk (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Juan R Rodrigues; Arthur Barazarte; José Camacho; Jaime Charris; Neira Gamboa; Michael Höpfner; Klaus Jung; Michael Lein; Bianca Nitzsche; Claudia Abramjuk
N'-Formyl-2-(5-nitrothiophen-2-yl)benzothiazole-6-carbohydrazide as a potential anti-tumour agent for prostate cancer in experimental studies.
The Journal of pharmacy and pharmacology 2013;65(3):411-22.
2012: Juan R Rodrigues; Jorge Angel; Jaime Charris; Rosa Ferrer; Neira Gamboa; Michael Hoepfner; Klaus Jung; Michael Lein; Bianca Nitzsche; Claudia Abramjuk
Effect of quinolinyl acrylate derivatives on prostate cancer in vitro and in vivo.
Investigational new drugs 2012;30(4):1426-33.
2012: Tobias Lange; Imke Müller; Michael F Nentwich; Guido Sauter; Thorsten Schlomm; Jennifer Schröder-Schwarz; Claudia Abramjuk; Mario Anders; Susanne Feldhaus; Olaf J C Hellwinkel; Hartwig Huland; Christine Knies; Katrin Stübke; Sebastian Ullrich; Robert L Vessella; Udo Schumacher
Human prostate cancer in a clinically relevant xenograft mouse model: identification of β(1,6)-branched oligosaccharides as a marker of tumor progression.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(5):1364-73.
2011: Juan Rodrigues; Claudia Abramjuk; Luis Vásquez; Neira Gamboa; José Domínguez; Bianca Nitzsche; Michael Höpfner; Radostina Georgieva; Hans Bäumler; Carsten Stephan; Klaus Jung; Michael Lein; Anja Rabien
New 4-maleamic acid and 4-maleamide peptidyl chalcones as potential multitarget drugs for human prostate cancer.
Pharmaceutical research 2011;28(4):907-19.
2009: Claudia Abramjuk; Michael Bueschges; Jörg Schnorr; Klaus Jung; Andrea Staack; Michael Lein
Divergent effects of taurolidine as potential anti-neoplastic agent: inhibition of bladder carcinoma cells in vitro and promotion of bladder tumor in vivo.
Oncology reports 2009;22(2):409-14.
2007: Claudia Abramjuk; Michael Lein; Winfried Rothaug; Hans-Willi Krell; Stefan A Loening; Klaus Jung
Enhanced inhibitory effect of the matrix metalloproteinase inhibitor Ro 28-2653 in combination with estramustine and etoposide on the prostate carcinoma in the rat Dunning orthotopic tumor model.
Cancer chemotherapy and pharmacology 2007;59(2):275-82.
2006: Ulrich Speck; Bruno Scheller; Claudia Abramjuk; Christoph Breitwieser; Juergen Dobberstein; Michael Boehm; Bernd Hamm
Neointima inhibition: comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries.
Radiology 2006;240(2):411-8.
2006: Jörg Schnorr; Susanne Wagner; Claudia Abramjuk; Randi Drees; Tania Schink; Eyk A Schellenberger; Herbert Pilgrimm; Bernd Hamm; Matthias Taupitz
Focal liver lesions: SPIO-, gadolinium-, and ferucarbotran-enhanced dynamic T1-weighted and delayed T2-weighted MR imaging in rabbits.
Radiology 2006;240(1):90-100.
2005: Michael Lein; Axel Semjonow; Markus Graefen; Maciej Kwiatkowski; Claudia Abramjuk; Carsten Stephan; Alexander Haese; fianceeyi chun; Dietmar Schnorr; Stefan A Loening; Klaus Jung
A multicenter clinical trial on the use of (-5, -7) pro prostate specific antigen.
The Journal of urology 2005;174(6):2150-3.
2005: Claudia Abramjuk; Klaus Jung; Hans-Willi Krell; Rolf Juchem; Robert Peters; Kasra Taymoorian; Andrea Staack; Carsten Stephan; Jörg Schnorr; Stefan A Loening; Michael Lein
Matrix metalloproteinase inhibitor Ro 28-2653 in combination with estramustine: tumor-reducing effects on hormone-sensitive prostate cancer in rats.
Anti-cancer drugs 2005;16(8):855-61.
2005: Ole Gemeinhardt; Lutz Lüdemann; D Prochnow; Claudia Abramjuk; Matthias Taupitz; Bernd Hamm; Dirk Beyersdorff
Differentiation of prostate cancer from normal prostate tissue in an animal model: conventional MRI and dynamic contrast-enhanced MRI.
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 2005;177(7):935-9.
2005: Ulrich Speck; Bruno Scheller; Claudia Abramjuk; Ulrich Bernhardt
Drug delivery by angiographic contrast media: inhibition of restenosis.
Academic radiology 2005;12 Suppl 1():S14-7.
2004: Jörg Schnorr; Susanne Wagner; Claudia Abramjuk; Ines Wojner; Tania Schink; Thomas Kroencke; Eyk A Schellenberger; Bernd Hamm; Herbert Pilgrimm; Matthias Taupitz
Comparison of the iron oxide-based blood-pool contrast medium VSOP-C184 with gadopentetate dimeglumine for first-pass magnetic resonance angiography of the aorta and renal arteries in pigs.
Investigative radiology 2004;39(9):546-53.
2004: Bruno Scheller; Ulrich Speck; Claudia Abramjuk; Ulrich Bernhardt; Michael Böhm; Georg Nickenig
Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis.
Circulation 2004;110(7):810-4.
2004: Ulrich Speck; Bruno Scheller; Claudia Abramjuk; Stephan Grossmann; Dirk Mahnkopf; Oliver Simon
Inhibition of restenosis in stented porcine coronary arteries: uptake of Paclitaxel from angiographic contrast media.
Investigative radiology 2004;39(3):182-6.
2004: Milos Sovak; Ron Terry; Claudia Abramjuk; Vera Faberová; Magdalena Fiserova; Milan Laznicek; Jost Leuschner; Jiri Malinak; Petr Zahradnik; Ondrej Masner; Allen L Seligson
Iosimenol, a low-viscosity nonionic dimer: preclinical physicochemistry, pharmacology, and pharmacokinetics.
Investigative radiology 2004;39(3):171-81.
2003: Jörg Schnorr; Susanne Wagner; W Ebert; C Heyer; G Laub; Dietmar Kivelitz; Claudia Abramjuk; Bernd Hamm; Matthias Taupitz
[MR angiography of the coronary arteries: comparison of the blood pool contrast medium Gadomer and Gd-DTPA in pigs].
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 2003;175(6):822-9.
2002: Matthias Taupitz; Jörg Schnorr; Susanne Wagner; Claudia Abramjuk; Herbert Pilgrimm; Dietmar Kivelitz; Tania Schink; Jörg Hansel; Gerhard Laub; Hanna Hünigen; Bernd Hamm
Coronary MR angiography: experimental results with a monomer-stabilized blood pool contrast medium.
Radiology 2002;222(1):120-6.
2000: Matthias Taupitz; Jörg Schnorr; Claudia Abramjuk; Susanne Wagner; Herbert Pilgrimm; H Hünigen; Bernd Hamm
New generation of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: preclinical results in rats and rabbits.
Journal of magnetic resonance imaging : JMRI 2000;12(6):905-11.